주요 콘텐츠로 건너뛰기

귀하의 브라우저가 완벽하게 지원되지 않습니다. 옵션이 있는 경우 최신 버전으로 업그레이드하거나 Mozilla Firefox, Microsoft Edge, Google Chrome 또는 Safari 14 이상을 사용하세요. 가능하지 않거나 지원이 필요한 경우 피드백을 보내주세요.

이 새로운 경험에 대한 귀하의 의견에 감사드립니다.의견을 말씀해 주세요새 탭/창에서 열기

Elsevier
엘스비어와 함께 출판

The European Molecular Biology Laboratory

Elsevier and The European Molecular Biology Laboratory (EMBL)새 탭/창에서 열기 have entered into an agreement detailed below which ensures authors publishing in Elsevier journals are compliant with this open access policy.

Agreement

EMBL requires electronic copies of any research articles that have been accepted for publication in a peer-reviewed journal, to be made open access as soon as possible and be available through Europe PubMed Central (Europe PMC) no later than six months after publication. This requirement applies to research supported in whole, or in part, by EMBL which is published from 15 June 2015 — discover the full open access policy새 탭/창에서 열기 of the European Molecular Biology Laboratory.

Gold open access

Authors can choose to publish gold open access in one of our established hybrid journals or in one of our open access journals새 탭/창에서 열기.

A publication fee is required to be paid in order to make an article open access. Authors are asked to check with EMBL on details regarding payment. Elsevier's open access publication fees range between c$150 and c$6,000 US Dollars excluding tax and are journal specific — please refer to the guide for authors on the journal homepage.

When publishing under either one of these open access options, the corresponding author will be given a choice of two Creative Commons licenses. EMBL policy states that authors choosing the gold open access route are required to select a Creative Commons Attribution (CC BY) license.

Elsevier will deposit the final published journal article in Europe PMC, on behalf of the author. The version that appears in PMC will have a CrossMark® identifier and link back to the authoritative version of record on ScienceDirect.

Please note: When publishing with Elsevier, the only way a researcher can comply with the EMBL OA policy is to select the gold open access ("author pays") option. Journals published by The Lancet, do not provide a gold open access option, but allow authors to self-archive their manuscript six months following publication (see green open access).

Green open access

Journals published by The Lancet allow EMBL funded authors to self-archive their accepted manuscript to Europe PMC after six months.

Please note: If you are a EMBL funded author and if any of your previously published Elsevier-published articles prior to 15 June 2015 are not available in Europe PMC, then you may use Elsevier's sharing policy to deposit papers in this repository. Deposits made via this route must adhere to the journal-specific embargo새 탭/창에서 열기. Such articles can be posted under a CC-BY-NC-ND license.

Help and support